Effect of matrine and cisplatin in combination on PDCD4 expression in SK-NEP-1 cells

MAO Ling, XUE Tian-Yang, XU Wei

Chinese Journal of Contemporary Pediatrics ›› 2014, Vol. 16 ›› Issue (2) : 115-119.

PDF(1644 KB)
PDF(1644 KB)
Chinese Journal of Contemporary Pediatrics ›› 2014, Vol. 16 ›› Issue (2) : 115-119. DOI: 10.7499/j.issn.1008-8830.2014.02.004
TOPIC OF HEMATOLOGY & ONCOLOGY

Effect of matrine and cisplatin in combination on PDCD4 expression in SK-NEP-1 cells

  • MAO Ling, XUE Tian-Yang, XU Wei
Author information +
History +

Abstract

Objective Matrine, a major ingredient of sophora, has an anti-tumor activity, capable of suppressing the proliferation and metastasis and promoting apoptosis or differentiation of tumor cells. This study was designed to investigate the effects of matrine on survival and apoptosis of nephroblastoma cell line SK-NEP-1, reduction of drugresistance of cisplatin and the mechanism(s) underlying these effects. Methods SK-NEP-1 cells were treated with matrine and cisplatin at various doses (0.5, 1.0 and 1.5 mg/mL), either each alone or in combination. The viability in treated SK-NEP-1 cells was assessed by MTT colorimetric assay, apoptosis by flow cytometry, and PDCD4 mRNA abundance by RT-PCR. Results As compared with the non-treatment control, matrine and cisplation, regardless of combination and dosage, significantly reduced the viability (P<0.01), induced apoptosis (P<0.01), and increased PDCD4 mRNA abundance (P<0.01), in SK-NEP-1 cells. The above effects of matrine and cisplation were dose-dependent when they were used alone, and were more pronounced when they were used in combination (P<0.05). Conclusions Matrine can significantly induce apoptosis and inhibit growth of SK-NEP-1 cells in a dose-dependent manner, thus increasing the chemotherapeutic sensibility of cisplatin. The observed effects of matrine may be a result of increased PDCD4 expressi on.

Key words

SK-NEP-1 cell / Matrine / Cisplation / Programmed cell death 4 / Child

Cite this article

Download Citations
MAO Ling, XUE Tian-Yang, XU Wei. Effect of matrine and cisplatin in combination on PDCD4 expression in SK-NEP-1 cells[J]. Chinese Journal of Contemporary Pediatrics. 2014, 16(2): 115-119 https://doi.org/10.7499/j.issn.1008-8830.2014.02.004

References

[1] Wang H, Shen Y, Sun N, et al. Identification and analysis of mutations in WTX and WT1 genes in peripheral blood and tumor tissue of children with Wilms' tumor[J]. China Medical Journal, 2012, 125(10): 1733-1739.
[2] 覃遵科, 殷小成. 苦参碱对急性淋巴细胞性白血病细胞Bcl-2 表达的影响[J]. 中国当代儿科杂志, 2004, 6(6): 497-499.
[3] 冯晨, 唐锁勤, 王建文, 等. 苦参碱抑制神经母细胞瘤LAN-5 细胞增殖及MYCN 基因mRNA 的表达[J]. 中国当代儿科 杂志, 2008, 10(2): 225-227.
[4] 周炳刚, 沈义军, 杨涛, 等. 苦参碱诱导人乳腺癌细胞凋亡 逆转耐药及对酸化蛋白激酶B、Fas、半胱氨酰天冬氨酸 特异性蛋白酶-3 表达的影响[J]. 中华实验外科杂志, 2012, 29(9): 1856-1857.
[5] 增辉, 胡梅洁, 张曙, 等. 苦参碱体外对胃癌细胞的杀伤作 用[J]. 上海第二医科大学学报, 2004, 24(1): 38-40.
[6] 殷飞, 赵军艳, 姚树坤. 苦参碱对肝癌SMMC-7721 细胞 JAK-STAT 信号通路的影响[J]. 中草药, 2008, 39(6): 873-877.
[7] 李屹, 张丽楠, 杨磊. 苦参碱药理作用研究进展[J]. 实用中医 药杂志, 2012, 28(5): 423-424.
[8] 何礼, 尚剑. 苦参碱抗肿瘤机制的研究进展[J]. 中医药信息, 2012, 29(4): 175-176.
[9] 孙建红, 武建军, 连月珍, 等. 苦参碱联合化疗药物对中晚 期肺癌的疗效分析[J]. 肿瘤药学杂志, 2013, 3(1): 48-50.
[10] Reynolds CP, Wang Y, Melton LJ, et al. Retinoic-acid-resistant neuroblastoma cell lines show altered MYC regulation and high sensitivity to fenretinide[J]. Med Pediatr Oncol, 2000, 35(6): 597-602.
[11] 崔明宇, 于启海, 陈海. 肾母细胞瘤组织中PTEN、PDCD4 的表达及意义[J]. 中华小儿外科杂志, 2011, 32(9): 645-649.
[12] Vikhreva PN, Shepelev MV, Korobko EV, et al. Pdcd4 tumor suppressor: properties, functions, and their application to oncology[J]. Mol Gen Mikrobiol Virusol, 2010, (2): 3-11.
PDF(1644 KB)

Accesses

Citation

Detail

Sections
Recommended

/